Managed by Pfizer Inc • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| $163.5M |
| 1.66M |
| 0.00% |
| — |
| 6 | A ARVN — | $66.3M | 3.46M | 0.00% | — |
| 7 | O ORIC — | $64.5M | 5.38M | 0.00% | — |
| 8 | T | $60.8M | 1.27M | 0.00% | — |
| 9 | O ORIC — | $54.6M | 5.38M | 0.00% | — |
| 10 | A ALLO — | $46.9M | 22.03M | 0.00% | — |
| 11 | O ORIC — | $44M | 5.38M | 0.00% | — |
| 12 | O ORIC — | $43.4M | 5.38M | 0.00% | — |
| 13 | A ARVN — | $41M | 3.46M | 0.00% | — |
| 14 | C CELC — | $34.8M | 349.4K | 0.00% | — |
| 15 | A ALLO — | $32.2M | 22.03M | 0.00% | — |
| 16 | W WVE — | $31.9M | 1.88M | 0.00% | — |
| 17 | A ALLO — | $30.2M | 22.03M | 0.00% | — |
| 18 | O ORIC — | $30M | 5.38M | 0.00% | — |
| 19 | A ARVN — | $29.5M | 3.46M | 0.00% | — |
| 20 | A ALLO — | $27.3M | 22.03M | 0.00% | — |